FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/03/064147 [Registered on: 14/03/2024] Trial Registered Prospectively
Last Modified On: 13/03/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Ability of Serratus Anterior Plane block in reducing post operative pain killer requirement after breast removal surgery 
Scientific Title of Study   EFFICACY AND SAFETY OF ULTRASOUND GUIDED SERRATUS ANTERIOR PLANE BLOCK IN REDUCING POST-OPERATIVE OPIODS REQUIREMENT IN PATIENTS UNDERGOING MASTECTOMY- A RANDOMIZED CONTROL TRIAL STUDY 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Pandu Ranga Rao Bangaru 
Designation  Post Graduate year 3 
Affiliation  JLN Medical college, Ajmer, Rajasthan 
Address  Department of Anesthesiology, JLN Medical college, Kala Bagh, Ajmer, Rajasthan 305001
Kala Bagh, Ajmer, Rajasthan 305001
Ajmer
RAJASTHAN
305001
India 
Phone  07799411443  
Fax    
Email  dr.pandurangarao@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr. Veena Patodi 
Designation  Senior Professor 
Affiliation  JLN Medical college, Ajmer, Rajasthan 
Address  Department of Anaesthesiology, JLN Medical college, Kala Bagh, Ajmer, Rajasthan 305001
Kala Bagh, Ajmer, Rajasthan 305001
Ajmer
RAJASTHAN
305001
India 
Phone  9414008276  
Fax    
Email  veenapatodi@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Pandu Ranga Rao Bangaru 
Designation  Post Graduate year 3 
Affiliation  JLN Medical college, Ajmer, Rajasthan 
Address  Department of Anaesthesiology, JLN Medical college, Kala Bagh, Ajmer, Rajasthan 305001
Kala Bagh, Ajmer, Rajasthan 305001

RAJASTHAN
305001
India 
Phone  07799411443  
Fax    
Email  dr.pandurangarao@gmail.com  
 
Source of Monetary or Material Support  
Departmrnt of Anaesthesiology New OT 1 st Floor JLN Medical college Ajmer Rajasthan 305001 
 
Primary Sponsor  
Name  JLN Medical college 
Address  Kala Bagh, Ajmer Rajasthan 305001 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Pandu Ranga Rao Bangaru  JLN Medical college  New OT, Department of Anaesthesiology, Kala Bagh, Ajmer, Rajasthan 305001
Ajmer
RAJASTHAN 
7799411443

dr.pandurangarao@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee JLN Medical college, Ajmer  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: C50||Malignant neoplasm of breast, (2) ICD-10 Condition: C509||Malignant neoplasm of breast of unspecified site, (3) ICD-10 Condition: O||Medical and Surgical,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Inj. Ropivacaine 0.2% for Serratus Anterior Plane block versus tramadol post operative rescue dosing for pain relief  With due approval from institutional ethical committee, the study will be conducted at Jawahar Lal Nehru Medical College, Ajmer, Rajasthan on patients undergoing mastectomies under general anaesthesia. This hospital based prospective randomized controlled clinical trial study is designed to include 60 female patients. Serratus anterior Plane block will be performed in plane to the ultrasound beam with a 22G, Quincke spinal needle. A total volume of 30 ml of 0.2 % ropivacaine(60 mg) will be given only once in the plane between Serratus Anterior muscle and latissimus dorsi muscle prior to shifting to operation theatre and induction of anaesthesia. A written informed consent will be taken in prior to procedure. Participants will be followed and monitored for duration of analgesia at specified intervals till they complain of pain in post-operative period then the study will be terminated. Data will be collected and analysed using standard qualitative and quantitative tests. A p value of less than 0.05 will be considered as significant 
Intervention  USG guided Serratus anterior plane block  With due approval from institutional ethical committee, the study will be conducted at Jawahar Lal Nehru Medical College, Ajmer, Rajasthan on patients undergoing mastectomies under general anaesthesia. This hospital based prospective randomized controlled clinical trial study is designed to include 60 female patients. Serratus anterior Plane block will be performed in plane to the ultrasound beam with a 22G, Quincke spinal needle. A total volume of 30 ml of 0.2 % ropivacaine(60 mg) will be given only once in the plane between Serratus Anterior muscle and latissimus dorsi muscle prior to shifting to operation theatre and induction of anaesthesia. A written informed consent will be taken in prior to procedure. Participants will be followed and monitored for duration of analgesia at specified intervals till they complain of pain in post-operative period then the study will be terminated. Data will be collected and analysed using standard qualitative and quantitative tests. A p value of less than 0.05 will be considered as significant 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Female 
Details  1. ASA 1 AND ASA 2.
2. Age 20 - 60 years of female sex.
3. Weighing between 40 and 75 kgs.
Undergoing mastectomies under general anesthesia will be included in
the stud 
 
ExclusionCriteria 
Details  1. Ineligible to provide informed consent
2. Younger than 20 years or older than 60 years of age.
3. Impaired kidney or renal functions history of alcohol or drug abuse.
4. History of chronic pain condition or daily intake of analgesics and
corticosteriods.
5. Uncontrolled systemic disease (DM, HTN)
6. Pregnant or lactating.
7. Any condition in which some drugs are contraindicated and
hypersensitivity. 
 
Method of Generating Random Sequence   Random Number Table 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Duration of Analgesia  To assess the duration of analgesia from time of extubation to demand
of first dose of rescue analgesic.
 
 
Secondary Outcome  
Outcome  TimePoints 
1. Total postoperative analgesic consumption.
2. Haemodynamic variables like HR, SBP, DBP, MBP, SPO2 intra
operatively and post operatively.
3. Side effect if any.
 
Every 5 minutes upto 30 minutes
Baseline, 5 mins,10mins,30 mins, 45 mins, 60 mins, 90 mins, 120 mins and 150 mins 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   30/03/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   With due approval from institutional ethical committee, the study will be conducted at Jawahar Lal Nehru Medical College, Ajmer, Rajasthan on patients undergoing mastectomies under general anaesthesia. This hospital based prospective randomized controlled clinical trial study is designed to include 60 female patients divided into 2 groups randomly. A written informed consent will be taken in prior to procedure. Participants will be followed and monitored for duration of analgesia at specified intervals till they complain of pain in post-operative period then the study will be terminated. Data will be collected and analysed using standard qualitative and quantitative tests. A p value of less than 0.05 will be considered as significant

Patients meeting the inclusion criteria during the pre-anaesthetic evaluation will be approached for consent, once the consent has been sought patients will be randomly assigned using computer generated tables into two groups of 30 patients each. Group A and Group B Group A – In this group, patient is taken into procedure room after verifying consent & NBM status and after being positioned supine and i.v access is secured after connecting to a cardiac monitor, vitals are measured. Ultrasound guided serratus anterior plane block will be performed in the mid axillary line at the level of 5 th rib with a 10 – 12 MHz transducer probe. Under aseptic precautions skin will be infiltrated with 2-3ml of 2% lignocaine with a 26 g h1/2 inch hypodermic needle. The block will be performed in plane to the ultrasound beam with a 22G, Quincke spinal needle. A total volume of 30 ml of 0.2 % ropivacaine will be given in the plane between Serratus Anterior muscle and latissimus dorsi muscle prior to shifting to operation theatre and induction of anaesthesia. Group B : Group B will be the control group. The patients in this group will receive intravenous Tramadol for pain relief in the post operative period
 
Close